JCGI vs. PEMB, IAT, FJV, FTV, BSV, SCP, BVT, BMD, EGL, and SMIF
Should you be buying JPMorgan China Growth & Income stock or one of its competitors? The main competitors of JPMorgan China Growth & Income include Pembroke VCT B (PEMB), Invesco Asia Trust (IAT), Fidelity Japan Trust (FJV), Foresight VCT (FTV), British Smaller Companies VCT (BSV), Schroder UK Mid Cap (SCP), Baronsmead Venture Trust (BVT), Baronsmead Second Venture Trust (BMD), Ecofin Global Utilities & Infra (EGL), and TwentyFour Select Monthly Income (SMIF). These companies are all part of the "asset management" industry.
Pembroke VCT B (LON:PEMB) and JPMorgan China Growth & Income (LON:JCGI) are both small-cap financial services companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, community ranking, earnings, valuation and profitability.
In the previous week, JPMorgan China Growth & Income had 3 more articles in the media than Pembroke VCT B. MarketBeat recorded 3 mentions for JPMorgan China Growth & Income and 0 mentions for Pembroke VCT B. Pembroke VCT B's average media sentiment score of 1.20 beat JPMorgan China Growth & Income's score of 0.00 indicating that JPMorgan China Growth & Income is being referred to more favorably in the news media.
Pembroke VCT B has a beta of -0.05, indicating that its stock price is 105% less volatile than the S&P 500. Comparatively, JPMorgan China Growth & Income has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500.
17.6% of JPMorgan China Growth & Income shares are held by institutional investors. 0.6% of Pembroke VCT B shares are held by company insiders. Comparatively, 1.3% of JPMorgan China Growth & Income shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Pembroke VCT B received 8 more outperform votes than JPMorgan China Growth & Income when rated by MarketBeat users.
Pembroke VCT B has higher revenue and earnings than JPMorgan China Growth & Income. Pembroke VCT B is trading at a lower price-to-earnings ratio than JPMorgan China Growth & Income, indicating that it is currently the more affordable of the two stocks.
JPMorgan China Growth & Income's return on equity of -6.58% beat Pembroke VCT B's return on equity.
Pembroke VCT B pays an annual dividend of GBX 5 per share and has a dividend yield of 5.1%. JPMorgan China Growth & Income pays an annual dividend of GBX 11 per share and has a dividend yield of 4.3%. Pembroke VCT B pays out -12,500.0% of its earnings in the form of a dividend. JPMorgan China Growth & Income pays out -2,156.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Pembroke VCT B is clearly the better dividend stock, given its higher yield and lower payout ratio.
Summary
Pembroke VCT B beats JPMorgan China Growth & Income on 8 of the 15 factors compared between the two stocks.
Get JPMorgan China Growth & Income News Delivered to You Automatically
Sign up to receive the latest news and ratings for JCGI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding JCGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
JPMorgan China Growth & Income Competitors List
Related Companies and Tools
